Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 GSK3 inhibitors: development and therapeutic potential.

× No keyword cloud information.

254 in total

Review 1. Targeting tau protein in Alzheimer's disease.

Authors: Cheng-Xin Gong; Inge Grundke-Iqbal; Khalid Iqbal
Journal: Drugs Aging Date: 2010-05 Impact factor: 3.923

2. O-linked beta-N-acetylglucosamine (O-GlcNAc) regulates stress-induced heat shock protein expression in a GSK-3beta-dependent manner.

Authors: Zahra Kazemi; Hana Chang; Sarah Haserodt; Cathrine McKen; Natasha E Zachara
Journal: J Biol Chem Date: 2010-10-06 Impact factor: 5.157

3. Integrin regulation of beta-catenin signaling in ovarian carcinoma.

Authors: Rebecca J Burkhalter; Jaime Symowicz; Laurie G Hudson; Cara J Gottardi; M Sharon Stack
Journal: J Biol Chem Date: 2011-04-25 Impact factor: 5.157

Review 4. GSK-3β activity and hyperdopamine-dependent behaviors.

Authors: Yan-Chun Li; Wen-Jun Gao
Journal: Neurosci Biobehav Rev Date: 2010-08-18 Impact factor: 8.989

5. Activating the translational repressor 4E-BP or reducing S6K-GSK3β activity prevents accelerated axon growth induced by hyperactive mTOR in vivo.

Authors: Xuan Gong; Longbo Zhang; Tianxiang Huang; Tiffany V Lin; Laura Miyares; John Wen; Lawrence Hsieh; Angélique Bordey
Journal: Hum Mol Genet Date: 2015-07-28 Impact factor: 6.150

Review 6. Uncoupling T-cell expansion from effector differentiation in cell-based immunotherapy.

Authors: Joseph G Crompton; Madhusudhanan Sukumar; Nicholas P Restifo
Journal: Immunol Rev Date: 2014-01 Impact factor: 12.988

7. Kinome chemoproteomics characterization of pyrrolo[3,4-c]pyrazoles as potent and selective inhibitors of glycogen synthase kinase 3.

Authors: Martin Golkowski; Gayani K Perera; Venkata Narayana Vidadala; Kayode K Ojo; Wesley C Van Voorhis; Dustin J Maly; Shao-En Ong
Journal: Mol Omics Date: 2018-02-12

8. Specific glycogen synthase kinase-3 inhibition reduces neuroendocrine markers and suppresses neuroblastoma cell growth.

Authors: Yvette M Carter; Selvi Kunnimalaiyaan; Herbert Chen; T Clark Gamblin; Muthusamy Kunnimalaiyaan
Journal: Cancer Biol Ther Date: 2014-02-12 Impact factor: 4.742

9. GSK3 alpha and beta are new functionally relevant targets of tivantinib in lung cancer cells.

Authors: Lily L Remsing Rix; Brent M Kuenzi; Yunting Luo; Elizabeth Remily-Wood; Fumi Kinose; Gabriela Wright; Jiannong Li; John M Koomen; Eric B Haura; Harshani R Lawrence; Uwe Rix
Journal: ACS Chem Biol Date: 2013-11-20 Impact factor: 5.100

10. Glycogen synthase kinase 3beta activation is a prerequisite signal for cytokine production and chemotaxis in human mast cells.

Authors: Madeleine Rådinger; Hye Sun Kuehn; Mi-Sun Kim; Dean D Metcalfe; Alasdair M Gilfillan
Journal: J Immunol Date: 2009-12-11 Impact factor: 5.422